VTv Historical Balance Sheet
VTVT Stock | USD 15.51 0.09 0.58% |
Trend analysis of vTv Therapeutics balance sheet accounts such as Total Assets of 10.5 M, Short Long Term Debt Total of 502.6 K, Other Current Liabilities of 5.7 M or Total Current Liabilities of 15 M provides information on VTv Therapeutics' total assets, liabilities, and equity, which is the actual value of vTv Therapeutics to its prevalent stockholders. By breaking down trends over time using VTv Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining vTv Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether vTv Therapeutics is a good buy for the upcoming year.
VTv Therapeutics Inventory |
|
VTv |
About VTv Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of vTv Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. VTv Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of VTv Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which VTv currently owns. An asset can also be divided into two categories, current and non-current.
VTv Therapeutics Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of VTv Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in vTv Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on VTv Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of vTv Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Capital Lease Obligations
VTv Therapeutics capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to VTv Therapeutics asset purchases. For example, VTv Therapeutics can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as VTv Therapeutics control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.Most accounts from VTv Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into vTv Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.At this time, VTv Therapeutics' Other Stockholder Equity is comparatively stable compared to the past year. Property Plant And Equipment Gross is likely to gain to about 1.1 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 5.7 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 932K | 716K | 529K | 502.6K | Total Assets | 25.5M | 33.2M | 11.0M | 10.5M |
VTv Therapeutics balance sheet Correlations
Click cells to compare fundamentals
VTv Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
VTv Therapeutics balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.3M | 14.8M | 25.5M | 33.2M | 11.0M | 10.5M | |
Short Long Term Debt Total | 7.1M | 915K | 932K | 716K | 529K | 502.6K | |
Other Current Liab | 4.8M | 4.0M | 6.0M | 4.7M | 6.0M | 5.7M | |
Total Current Liabilities | 13.4M | 6.4M | 8.5M | 7.7M | 10.6M | 15.0M | |
Total Stockholder Equity | (49.0M) | (80.1M) | (9.7M) | (10.7M) | (24.7M) | (25.9M) | |
Other Liab | 3.9M | 3.9M | 1.3M | 19.4M | 17.4M | 18.3M | |
Property Plant And Equipment Net | 1.0M | 849K | 680K | 556K | 361K | 343.0K | |
Net Debt | 5.3M | (4.8M) | (12.5M) | (11.4M) | (8.9M) | (8.5M) | |
Retained Earnings | (233.5M) | (290.0M) | (248.8M) | (265.5M) | (281.0M) | (295.1M) | |
Accounts Payable | 7.1M | 1.9M | 1.9M | 2.5M | 4.1M | 4.8M | |
Cash | 1.8M | 5.7M | 13.4M | 12.1M | 9.4M | 14.4M | |
Non Current Assets Total | 6.4M | 7.6M | 9.9M | 6.1M | 361K | 343.0K | |
Non Currrent Assets Other | 2.5M | 2.9M | (7.6M) | (6.1M) | (5.5M) | (5.3M) | |
Other Assets | 4.8M | 2.5M | 2.9M | 7.2M | 8.3M | 8.7M | |
Cash And Short Term Investments | 1.8M | 5.7M | 13.4M | 12.1M | 9.4M | 14.4M | |
Net Receivables | 5K | 158K | 57K | 12.4M | 102K | 96.9K | |
Common Stock Shares Outstanding | 757.3K | 1.2M | 1.6M | 1.9M | 2.1M | 1.9M | |
Short Term Investments | 250K | 371K | 100K | 15K | 65K | 61.8K | |
Liabilities And Stockholders Equity | 9.3M | 14.8M | 25.5M | 33.2M | 11.0M | 10.5M | |
Non Current Liabilities Total | 44.9M | 88.5M | 26.7M | 36.3M | 18.9M | 18.0M | |
Other Current Assets | 806K | 939K | 2.1M | 2.5M | 1.1M | 1.1M | |
Other Stockholder Equity | 183.9M | 209.2M | 238.2M | 254.8M | 256.3M | 269.2M | |
Total Liab | 58.3M | 94.9M | 35.2M | 44.0M | 29.6M | 28.1M | |
Property Plant And Equipment Gross | 1.0M | 367K | 680K | 556K | 848K | 1.1M | |
Total Current Assets | 2.8M | 7.2M | 15.6M | 27.1M | 10.7M | 16.9M | |
Short Term Debt | 6.3M | 394K | 624K | 532K | 529K | 502.6K | |
Property Plant Equipment | 1.0M | 367K | 680K | 207K | 186.3K | 177.0K | |
Net Tangible Assets | (49.0M) | 3.8M | (9.7M) | 5.8M | 6.7M | 7.1M | |
Short Long Term Debt | 6.2M | 84K | 256K | 224K | 191K | 181.5K | |
Common Stock Total Equity | 435K | 641K | 541K | 1.0M | 1.2M | 1.3M | |
Capital Surpluse | 150.6M | 183.9M | 209.2M | 253.7M | 291.8M | 183.4M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VTv Stock Analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.